Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP) [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating ketamine-assisted psychotherapy for adolescents with posttraumatic stress disorder has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Posttraumatic Stress Disorder | EARLY_Phase 1 | Status: SUSPENDED